<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">porozendo</journal-id><journal-title-group><journal-title xml:lang="ru">Остеопороз и остеопатии</journal-title><trans-title-group xml:lang="en"><trans-title>Osteoporosis and Bone Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-2680</issn><issn pub-type="epub">2311-0716</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/osteo13201</article-id><article-id custom-type="elpub" pub-id-type="custom">porozendo-13201</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>X-сцепленный остеопороз/несовершенный остеогенез вследствие мутации в гене PLS3: первое описание в России</article-title><trans-title-group xml:lang="en"><trans-title>X-linked osteoporosis/osteogenesis imperfecta due to a PLS3 mutation: the first description in Russia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9783-3599</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мамедова</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Mamedova</surname><given-names>E. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мамедова Елизавета Октаевна - к.м.н.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Elizaveta O. Mamedova - MD, PhD.</p><p>11 Dm.Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">lilybet@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7960-8315</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сенюшкина</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Senyshkina</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сенюшкина Евгения Семеновна.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Evgeniya S. Senyushkina - MD.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">evgeniyasenyushkina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9065-7791</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурякина</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Buryakina</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бурякина Светлана Алексеевна - к.м.н.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Svetlana A. Buryakina - MD, PhD.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">sburyakina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-6173-2145</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарасова Елена Вячеславовна.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Elena V. Tarasova - MD.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-6162-8461</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнов Кирилл Вячеславович.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Kirill V. Smirnov.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">smirnov.kirill@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9789-9555</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салахов</surname><given-names>Р. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Salakhov</surname><given-names>R. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Салахов Рамиль Ринатович - к.м.н.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Ramil R. Slakhov - MD, PhD.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">ramil.salakhov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8643-850X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хусаинова</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Khusainova</surname><given-names>R. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хусаинова Рита Игоревна - д.б.н., профессор.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Rita I. Khusainova - PhD, Professor.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">khusainova.rita@endocrincntr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6674-6441</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белая</surname><given-names>Ж. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Belaya</surname><given-names>Zh. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белая Жанна Евгеньевна - д.м.н., профессор.</p><p>117292, Москва, улица Дм. Ульянова, д. 11</p></bio><bio xml:lang="en"><p>Zhanna E. Belaya - MD, PhD, Professor.</p><p>11 Dm. Ulyanova street, 117292 Moscow</p></bio><email xlink:type="simple">jannabelaya@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ГНЦ РФ ФГБУ «НМИЦ эндокринологии» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Endocrinology Research Centre<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2025</year></pub-date><volume>28</volume><issue>2</issue><fpage>19</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мамедова Е.О., Сенюшкина Е.С., Бурякина С.А., Тарасова Е.В., Смирнов К.В., Салахов Р.Р., Хусаинова Р.И., Белая Ж.Е., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Мамедова Е.О., Сенюшкина Е.С., Бурякина С.А., Тарасова Е.В., Смирнов К.В., Салахов Р.Р., Хусаинова Р.И., Белая Ж.Е.</copyright-holder><copyright-holder xml:lang="en">Mamedova E.O., Senyshkina E.S., Buryakina S.A., Tarasova E.V., Smirnov K.V., Salakhov R.R., Khusainova R.I., Belaya Z.E.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.osteo-endojournals.ru/jour/article/view/13201">https://www.osteo-endojournals.ru/jour/article/view/13201</self-uri><abstract><p>Остеопороз, манифестирующий в детском возрасте, а также у молодых взрослых, представляет сложности для дифференциальной диагностики. У молодых людей самой частой причиной первичного остеопороза является несовершенный остеогенез (НО). В 2013 г. впервые были описаны 5 семей с X-сцепленным остеопорозом и остеопоротическими переломами, манифестировавшими с детского возраста, у мужчин, у которых были выявлены патогенные варианты в гене PLS3. Ген PLS3 расположен на Х-хромосоме (Xq23) и кодирует белок пластин 3, основная функция которого — связывание и группирование молекул F-актина — основного компонента цитоскелета. В настоящее время в литературе описано около 50 мужчин с этим заболеванием.</p><p>В статье представлено описание Х-сцепленного остеопороза/НО у двух братьев, у которых при проведении молекулярно-генетического исследования были выявлены гемизиготные мутации в гене PLS3 ((NM_005032.7) c.836_837dup (p.His280Phefs*43)). У обоих братьев переломы начали происходить с детского возраста (кости предплечий, а у старшего брата также перелом плечевой кости и перелом большого вертела), а в последующем были выявлены множественные компрессионные переломы тел позвонков. Нарушений фосфорно-кальциевого обмена у обоих братьев выявлено не было, при проведении рентгеновской денситометрии выявлено снижение минеральной плотности кости (МПК). У старшего брата начато лечение терипаратидом, младший брат находится на лечении золедроновой кислотой, на этом фоне новых переломов за время наблюдения не отмечено.</p><p>Оба сибса получили данный вариант в гене PLS3 от матери, у которой вариант выявлен в гетерозиготном состоянии. У матери пациентов диагностированы первичный гиперпаратиреоз с множественным поражением околощитовидных желез и тяжелый остеопороз с двумя компрессионными переломами тел двух грудных позвонков и выраженным снижением МПК в позвонках. В России случаи X-сцепленного остеопороза/НО вследствие мутаций в гене PLS3 ранее не описаны. Случаи первичного гиперпаратиреоза у пациентов с мутациями в PLS3 не описаны в литературе.</p></abstract><trans-abstract xml:lang="en"><p>The differential diagnosis of osteoporosis in children and young adults is a challenge. In young people, the most common cause of primary osteoporosis is osteogenesis imperfecta (OI). In 2013, 5 families with X-linked osteoporosis and osteoporotic fractures manifesting in childhood were described for the first time in men who had pathogenic variants in the PLS3 gene. The PLS3 gene is located on the X chromosome (Xq23) and encodes the protein plastin 3, the main function of which is to bind and group F-actin molecules, the main component of the cytoskeleton. Currently, about 50 men with this disease have been described in the literature.</p><p>In this article, two brothers with X-linked osteoporosis/OI are described, in whom hemizygous mutations in the PLS3 gene ((NM_005032.7) c.836_837dup (p.His280Phefs*43) were detected. In both brothers, fractures have occurred since childhood (forearm bones, and in the elder brother also a fracture of the humerus and a fracture of the greater trochanter), and later multiple compression fractures of the vertebrae were detected. No disorders of mineral metabolism were detected in both brothers, but bone mineral density (BMD) measured by DEXA was decreased. The elder brother is treated with teriparatide, the younger brother is treated with zoledronic acid, and new fractures were not detected during a short follow-up.</p><p>Both brothers received this PLS3 variant from their mother, in whom it was heterozygous. She was diagnosed with primary hyperparathyroidism with multiple parathyroid adenomas and severe osteoporosis with two thoracic vertebral compression fractures and decrease in spinal BMD. In Russia, cases of X-linked osteoporosis/OI due to mutations in the PLS3 gene have not been previously described. Cases of primary hyperparathyroidism in patients with PLS3 mutations have not been described in the literature.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>X-сцепленный остеопороз</kwd><kwd>несовершенный остеогенез</kwd><kwd>пластин 3</kwd><kwd>PLS3</kwd><kwd>первичный гиперпаратиреоз</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>X-linked osteoporosis</kwd><kwd>osteogenesis imperfecta</kwd><kwd>plastin 3</kwd><kwd>PLS3</kwd><kwd>primary hyperparathyroidism</kwd><kwd>case report</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Работа выполнена в рамках государственного задания «Новые технологии диагностики и дифференциальной диагностики первичного и вторичного остеопороза на фоне эндокринопатий и орфанных заболеваний скелета» № 124020700097-8.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Mäkitie O, Zillikens MC. Early-Onset Osteoporosis. Calcif Tissue Int. 2022;110(5):546-561. doi: https://doi.org/10.1007/s00223-021-00885-6</mixed-citation><mixed-citation xml:lang="en">Mäkitie O, Zillikens MC. Early-Onset Osteoporosis. Calcif Tissue Int. 2022;110(5):546-561. doi: https://doi.org/10.1007/s00223-021-00885-6</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marrani E, Giani T, Simonini G, Cimaz R. Pediatric Osteoporosis: Diagnosis and Treatment Considerations. Drugs. 2017;77(6):679-695. doi: https://doi.org/10.1007/s40265-017-0715-3</mixed-citation><mixed-citation xml:lang="en">Marrani E, Giani T, Simonini G, Cimaz R. Pediatric Osteoporosis: Diagnosis and Treatment Considerations. Drugs. 2017;77(6):679-695. doi: https://doi.org/10.1007/s40265-017-0715-3</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Jovanovic M, Guterman-Ram G, Marini JC. Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types. Endocr Rev. 2022;43(1):61-90. doi: https://doi.org/10.1210/endrev/bnab017</mixed-citation><mixed-citation xml:lang="en">Jovanovic M, Guterman-Ram G, Marini JC. Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types. Endocr Rev. 2022;43(1):61-90. doi: https://doi.org/10.1210/endrev/bnab017</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Зарипова А.Р., Надыршина Д.Д., Хусаинова Р.И. Спектр и частоты патогенных изменений у пациентов с несовершенным остеогенезом из Республики Башкортостан. Медицинская генетика. — 2022. — Т.21.— №9. — С.41-44. doi: https://doi.org/10.25557/2073-7998.2022.09.41-44</mixed-citation><mixed-citation xml:lang="en">Zaripova A, Nadyrshina D, Khusainova R. Spectrum and frequency of pathogenic changes in patients with incomplete osteogenesis from the Republic of Bashkortostan. Medical Genetics. 2022;21(9):41-44. (In Russ.) doi: https://doi.org/10.25557/2073-7998.2022.09.41-44</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi V, Lee B, Marom R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr. 2019;31(6):708-715. doi: https://doi.org/10.1097/MOP.0000000000000813</mixed-citation><mixed-citation xml:lang="en">Rossi V, Lee B, Marom R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr. 2019;31(6):708-715. doi: https://doi.org/10.1097/MOP.0000000000000813</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jovanovic M, Marini JC. Update on the Genetics of Osteogenesis Imperfecta. Calcif Tissue Int. 2024;115(6):891-914. doi: https://doi.org/10.1007/s00223-024-01266-5</mixed-citation><mixed-citation xml:lang="en">Jovanovic M, Marini JC. Update on the Genetics of Osteogenesis Imperfecta. Calcif Tissue Int. 2024;115(6):891-914. doi: https://doi.org/10.1007/s00223-024-01266-5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Меркурьева Е.С. Клинико-генетические характеристики изолированных и синдромальных форм несовершенного остеогенеза: Дис. … канд. мед. наук. — Москва; 2024. Доступно по: https://api.med-gen.ru/site/assets/files/3370/disser_merkureva_e_s_1.pdf. Ссылка активна на 28.03.2025 г.</mixed-citation><mixed-citation xml:lang="en">Merkur’eva ES. Kliniko-geneticheskie harakteristiki izolirovannyh i sindromal’nyh form nesovershennogo osteogeneza [dissertation] Moscow; 2024. (in Russ.) Доступно по: https://api.med-gen.ru/site/assets/files/3370/disser_merkureva_e_s_1.pdf. Ссылка активна на 28.03.2025 г.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zaripova AR, Khusainova RI. Modern classification and molecular-genetic aspects of osteogenesis imperfecta. Vavilovskii Zhurnal Genet Selektsii. 2020;24(2):219-227. doi: https://doi.org/10.18699/VJ20.614</mixed-citation><mixed-citation xml:lang="en">Zaripova AR, Khusainova RI. Modern classification and molecular-genetic aspects of osteogenesis imperfecta. Vavilovskii Zhurnal Genet Selektsii. 2020;24(2):219-227. doi: https://doi.org/10.18699/VJ20.614</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">van Dijk FS, Zillikens MC, Micha D, et al. PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med. 2013;369(16):1529-1536. doi: https://doi.org/10.1056/NEJMoa1308223</mixed-citation><mixed-citation xml:lang="en">van Dijk FS, Zillikens MC, Micha D, et al. PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med. 2013;369(16):1529-1536. doi: https://doi.org/10.1056/NEJMoa1308223</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wolff L, Strathmann EA, Müller I, et al. Plastin 3 in health and disease: a matter of balance. Cell Mol Life Sci. 2021;78(13):5275-5301. doi: https://doi.org/10.1007/s00018-021-03843-5</mixed-citation><mixed-citation xml:lang="en">Wolff L, Strathmann EA, Müller I, et al. Plastin 3 in health and disease: a matter of balance. Cell Mol Life Sci. 2021;78(13):5275-5301. doi: https://doi.org/10.1007/s00018-021-03843-5</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhong W, Pathak JL, Liang Y, et al. The intricate mechanism of PLS3 in bone homeostasis and disease. Front Endocrinol (Lausanne). 2023;14:1168306. doi: https://doi.org/10.3389/fendo.2023.1168306</mixed-citation><mixed-citation xml:lang="en">Zhong W, Pathak JL, Liang Y, et al. The intricate mechanism of PLS3 in bone homeostasis and disease. Front Endocrinol (Lausanne). 2023;14:1168306. doi: https://doi.org/10.3389/fendo.2023.1168306</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hu J, Li LJ, Zheng WB, et al. A novel mutation in PLS3 causes extremely rare X-linked osteogenesis imperfecta. Mol Genet Genomic Med. 2020;8(12):e1525. doi: https://doi.org/10.1002/mgg3.1525</mixed-citation><mixed-citation xml:lang="en">Hu J, Li LJ, Zheng WB, et al. A novel mutation in PLS3 causes extremely rare X-linked osteogenesis imperfecta. Mol Genet Genomic Med. 2020;8(12):e1525. doi: https://doi.org/10.1002/mgg3.1525</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brlek P, Antičević D, Molnar V, et al. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in PLS3. Genes (Basel). 2021;12(12):1851. doi: https://doi.org/10.3390/genes12121851</mixed-citation><mixed-citation xml:lang="en">Brlek P, Antičević D, Molnar V, et al. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in PLS3. Genes (Basel). 2021;12(12):1851. doi: https://doi.org/10.3390/genes12121851</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Z, Feng Z, Zhu X, et al. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis. Orphanet J Rare Dis. 2022;17(1):247. Published 2022 Jun 25. doi: https://doi.org/10.1186/s13023-022-02380-z</mixed-citation><mixed-citation xml:lang="en">Wu Z, Feng Z, Zhu X, et al. Identification of a novel splicing mutation and genotype-phenotype correlations in rare PLS3-related childhood-onset osteoporosis. Orphanet J Rare Dis. 2022;17(1):247. Published 2022 Jun 25. doi: https://doi.org/10.1186/s13023-022-02380-z</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu C, Li QW, Zhang L, Liu XL. X-linked osteogenesis imperfecta accompanied by patent ductus arteriosus: a case with a novel splice variant in PLS3. World J Pediatr. 2022;18(7):515-519. doi: https://doi.org/10.1007/s12519-022-00539-z</mixed-citation><mixed-citation xml:lang="en">Qiu C, Li QW, Zhang L, Liu XL. X-linked osteogenesis imperfecta accompanied by patent ductus arteriosus: a case with a novel splice variant in PLS3. World J Pediatr. 2022;18(7):515-519. doi: https://doi.org/10.1007/s12519-022-00539-z</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tüysüz B, Elkanova L, Uludağ Alkaya D, et al. Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants. Bone. 2022;155:116293. doi: https://doi.org/10.1016/j.bone.2021.116293</mixed-citation><mixed-citation xml:lang="en">Tüysüz B, Elkanova L, Uludağ Alkaya D, et al. Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants. Bone. 2022;155:116293. doi: https://doi.org/10.1016/j.bone.2021.116293</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Apperley LJ, Albaba S, Dharmaraj P, Balasubramanian M. PLS3 whole gene deletion as a cause of X-linked osteoporosis: Clinical report with review of published PLS3 literature. Clin Dysmorphol. 2023;32(1):43-47. doi: https://doi.org/10.1097/MCD.0000000000000442</mixed-citation><mixed-citation xml:lang="en">Apperley LJ, Albaba S, Dharmaraj P, Balasubramanian M. PLS3 whole gene deletion as a cause of X-linked osteoporosis: Clinical report with review of published PLS3 literature. Clin Dysmorphol. 2023;32(1):43-47. doi: https://doi.org/10.1097/MCD.0000000000000442</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mancini M, Chapurlat R, Isidor B, et al. Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene. Calcif Tissue Int. 2024;115(5):591-598. doi: https://doi.org/10.1007/s00223-024-01288-z.</mixed-citation><mixed-citation xml:lang="en">Mancini M, Chapurlat R, Isidor B, et al. Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene. Calcif Tissue Int. 2024;115(5):591-598. doi: https://doi.org/10.1007/s00223-024-01288-z.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Aliyeva L, Ongen YD, Eren E, et al. Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta. J Mol Diagn. 2024;26(9):754-769. doi: https://doi.org/10.1016/j.jmoldx.2024.05.014</mixed-citation><mixed-citation xml:lang="en">Aliyeva L, Ongen YD, Eren E, et al. Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta. J Mol Diagn. 2024;26(9):754-769. doi: https://doi.org/10.1016/j.jmoldx.2024.05.014</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Costa A, Martins A, Machado C, et al. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Genetic Features in Five New Families. Calcif Tissue Int. 2024;114(2):157-170. doi: https://doi.org/10.1007/s00223-023-01162-4</mixed-citation><mixed-citation xml:lang="en">Costa A, Martins A, Machado C, et al. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Genetic Features in Five New Families. Calcif Tissue Int. 2024;114(2):157-170. doi: https://doi.org/10.1007/s00223-023-01162-4</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kämpe AJ, Costantini A, Mäkitie RE, et al. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants. Osteoporos Int. 2017;28(10):3023-3032. doi: https://doi.org/10.1007/s00198-017-4150-9</mixed-citation><mixed-citation xml:lang="en">Kämpe AJ, Costantini A, Mäkitie RE, et al. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants. Osteoporos Int. 2017;28(10):3023-3032. doi: https://doi.org/10.1007/s00198-017-4150-9</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Shao C, Wang YW, He JW, Fu WZ, Wang C, Zhang ZL. Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women. Acta Pharmacol Sin. 2019;40(9):1212-1218. doi: https://doi.org/10.1038/s41401-019-0219-7</mixed-citation><mixed-citation xml:lang="en">Shao C, Wang YW, He JW, Fu WZ, Wang C, Zhang ZL. Genetic variants in the PLS3 gene are associated with osteoporotic fractures in postmenopausal Chinese women. Acta Pharmacol Sin. 2019;40(9):1212-1218. doi: https://doi.org/10.1038/s41401-019-0219-7</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Laine CM, Wessman M, Toiviainen-Salo S, et al. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis. J Bone Miner Res. 2015;30(3):510-518. doi: https://doi.org/10.1002/jbmr.2355</mixed-citation><mixed-citation xml:lang="en">Laine CM, Wessman M, Toiviainen-Salo S, et al. A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis. J Bone Miner Res. 2015;30(3):510-518. doi: https://doi.org/10.1002/jbmr.2355</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Bian X, Cheng G, et al. A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family. Ann Hum Genet. 2020;84(1):92-96. doi: https://doi.org/10.1111/ahg.12344</mixed-citation><mixed-citation xml:lang="en">Wang L, Bian X, Cheng G, et al. A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family. Ann Hum Genet. 2020;84(1):92-96. doi: https://doi.org/10.1111/ahg.12344</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Välimäki VV, Mäkitie O, Pereira R, et al. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study. J Clin Endocrinol Metab. 2017;102(2):535-544. doi: https://doi.org/10.1210/jc.2016-2423</mixed-citation><mixed-citation xml:lang="en">Välimäki VV, Mäkitie O, Pereira R, et al. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study. J Clin Endocrinol Metab. 2017;102(2):535-544. doi: https://doi.org/10.1210/jc.2016-2423</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Neugebauer J, Heilig J, Hosseinibarkooie S, et al. Plastin 3 influences bone homeostasis through regulation of osteoclast activity. Hum Mol Genet. 2018;27(24):4249-4262. doi: https://doi.org/10.1093/hmg/ddy318</mixed-citation><mixed-citation xml:lang="en">Neugebauer J, Heilig J, Hosseinibarkooie S, et al. Plastin 3 influences bone homeostasis through regulation of osteoclast activity. Hum Mol Genet. 2018;27(24):4249-4262. doi: https://doi.org/10.1093/hmg/ddy318</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wesseling-Perry K, Mäkitie RE, Välimäki VV, et al. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3. J Clin Endocrinol Metab. 2017;102(7):2340-2348. doi: https://doi.org/10.1210/jc.2017-00099</mixed-citation><mixed-citation xml:lang="en">Wesseling-Perry K, Mäkitie RE, Välimäki VV, et al. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3. J Clin Endocrinol Metab. 2017;102(7):2340-2348. doi: https://doi.org/10.1210/jc.2017-00099</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Petit F, Longoni M, Wells J, et al. PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects. Am J Hum Genet. 2023;110(10):1787-1803. doi: https://doi.org/10.1016/j.ajhg.2023.09.002</mixed-citation><mixed-citation xml:lang="en">Petit F, Longoni M, Wells J, et al. PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects. Am J Hum Genet. 2023;110(10):1787-1803. doi: https://doi.org/10.1016/j.ajhg.2023.09.002</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Fahiminiya S, Majewski J, Al-Jallad H, et al. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. J Bone Miner Res. 2014;29(8):1805-1814. doi: https://doi.org/10.1002/jbmr.2208</mixed-citation><mixed-citation xml:lang="en">Fahiminiya S, Majewski J, Al-Jallad H, et al. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. J Bone Miner Res. 2014;29(8):1805-1814. doi: https://doi.org/10.1002/jbmr.2208</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">van de Laarschot DM, Zillikens MC. Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation. Bone. 2016;91:148-151. doi: https://doi.org/10.1016/j.bone.2016.07.022</mixed-citation><mixed-citation xml:lang="en">van de Laarschot DM, Zillikens MC. Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation. Bone. 2016;91:148-151. doi: https://doi.org/10.1016/j.bone.2016.07.022</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kaifer KA, Villalón E, Osman EY, et al. Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy. JCI Insight. 2017;2(5):e89970. doi: https://doi.org/10.1172/jci.insight.89970</mixed-citation><mixed-citation xml:lang="en">Kaifer KA, Villalón E, Osman EY, et al. Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy. JCI Insight. 2017;2(5):e89970. doi: https://doi.org/10.1172/jci.insight.89970</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Yang YS, Xie J, Wang D, et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019;10(1):2958. doi:10.1038/s41467-019-10809-6</mixed-citation><mixed-citation xml:lang="en">Yang YS, Xie J, Wang D, et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun. 2019;10(1):2958. doi:10.1038/s41467-019-10809-6</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Schindeler A, Lee LR, O’Donohue AK, Ginn SL, Munns CF. Curative Cell and Gene Therapy for Osteogenesis Imperfecta. J Bone Miner Res. 2022;37(5):826-836. doi: https://doi.org/10.1002/jbmr.4549</mixed-citation><mixed-citation xml:lang="en">Schindeler A, Lee LR, O’Donohue AK, Ginn SL, Munns CF. Curative Cell and Gene Therapy for Osteogenesis Imperfecta. J Bone Miner Res. 2022;37(5):826-836. doi: https://doi.org/10.1002/jbmr.4549</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
